Qian Liu
Company: Oxgene Inc
Job title: Head of Plasmid Engineering & LVV
Seminars:
XOFLX™ Stable Technology: a Simplified High- Yielding LVV Manufacturing System that Lowers Costs & Improves Process Consistency 1:00 pm
WuXi Advanced Therapies is dedicated to supporting our cell therapy partners throughout their path to clinic and patient care Our innovative XOFLX™ (pronounced So-flex) stable technology was developed to meet the industry need for large quantities of high-quality lentiviral vectors (LVV) with demonstrated safety and efficacy By reducing or eliminating the requirement for plasmid input…Read more
day: Day 1 - Track C - AM